Your browser doesn't support javascript.
loading
[Contribution of connected prescriptions (NetSIG) for the management of molecular pathology exams]. / Apport de la prescription connectée (NetSIG) dans la prise en charge et la gestion des examens de pathologie moléculaire.
Martin, Laurent; Chapusot, Caroline; Tarris, Georges; Remond, Alicia; Millière, Alice; Pioche, Célia; Dubois, Jessie; Laffage, Nathalie; Aubry, Manon; Dubois, Lyse Marie; Andrianiaina, Haingo; Provost, Noelle; Funes de la Vega, Mathilde; Grangier, Nadège; Harizay, Fara; Douchet, Catherine; Tournier, Benjamin; Guibert, Camille; Aubriot-Lorton, Marie Hélène.
Afiliación
  • Martin L; Service de pathologie, CHU de Dijon, Dijon, France; Plateforme de génétique somatique des cancers de Bourgogne, CHU de Dijon, Dijon, France. Electronic address: laurent.martin@chu-dijon.fr.
  • Chapusot C; Service de pathologie, CHU de Dijon, Dijon, France; Plateforme de génétique somatique des cancers de Bourgogne, CHU de Dijon, Dijon, France.
  • Tarris G; Service de pathologie, CHU de Dijon, Dijon, France.
  • Remond A; Service de pathologie, CHU de Dijon, Dijon, France; Plateforme de génétique somatique des cancers de Bourgogne, CHU de Dijon, Dijon, France.
  • Millière A; Service de pathologie, CHU de Dijon, Dijon, France.
  • Pioche C; Service de pathologie, CHU de Dijon, Dijon, France; Plateforme de génétique somatique des cancers de Bourgogne, CHU de Dijon, Dijon, France.
  • Dubois J; Service de pathologie, CHU de Dijon, Dijon, France.
  • Laffage N; Service de pathologie, CHU de Dijon, Dijon, France.
  • Aubry M; Service de pathologie, CHU de Dijon, Dijon, France; Plateforme de génétique somatique des cancers de Bourgogne, CHU de Dijon, Dijon, France.
  • Dubois LM; Service de pathologie, CHU de Dijon, Dijon, France; Plateforme de génétique somatique des cancers de Bourgogne, CHU de Dijon, Dijon, France.
  • Andrianiaina H; Service de pathologie, CHU de Dijon, Dijon, France.
  • Provost N; Service de pathologie, CHU de Dijon, Dijon, France.
  • Funes de la Vega M; Service de pathologie, CHU de Dijon, Dijon, France.
  • Grangier N; Service de pathologie, CHU de Dijon, Dijon, France; Plateforme de génétique somatique des cancers de Bourgogne, CHU de Dijon, Dijon, France.
  • Harizay F; Service de pathologie, CHU de Dijon, Dijon, France.
  • Douchet C; Service de pathologie, CHU de Dijon, Dijon, France.
  • Tournier B; Service de pathologie, CHU de Dijon, Dijon, France; Plateforme de génétique somatique des cancers de Bourgogne, CHU de Dijon, Dijon, France.
  • Guibert C; Service de pathologie, CHU de Dijon, Dijon, France.
  • Aubriot-Lorton MH; Service de pathologie, CHU de Dijon, Dijon, France; Plateforme de génétique somatique des cancers de Bourgogne, CHU de Dijon, Dijon, France.
Ann Pathol ; 2024 Mar 18.
Article en Fr | MEDLINE | ID: mdl-38503611
ABSTRACT

INTRODUCTION:

This study describes our experience implementing a connected prescription software (NetSIG, Terascop) for molecular pathology exams. MATERIAL AND

METHODS:

NetSIG was set up for liquid biopsies and tissue testing. After registration and activation of regional pathology laboratories, NetSIG was implemented for external then internal prescriptions.

RESULTS:

NetSIG allows users to follow up on all prescriptions on the website, to interact through messages and to consult reports after validation. External set up was quick (3-4 months) and comprehensive (>70%). Prescriptions were made by physicians or more often by secretaries or referring pathologists. Internal prescriptions were made by pathologists then registered in NetSIG by our secretaries. This deployment strategy has resulted in very good completeness of prescriptions (>90%). DISCUSSION AND

CONCLUSION:

Connected prescriptions made this complex circuit more fluid and facilitated the redistribution of different administrative and technical tasks. The number of phone calls decreased sharply. Half of the prescriptions were made by pathologists and half by oncologists (physicians or secretaries). The mean dearchiving duration for blocks was one day. Mean forwarding of blocks was 2.5 days. Mean turnaround time was 8 days for targeted techniques and 13 days for Next Generation Sequencing. Physicians appreciated the interactivity of the software and the fact that they could consult it on a smartphone.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: Fr Revista: Ann Pathol Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: Fr Revista: Ann Pathol Año: 2024 Tipo del documento: Article
...